Efficacy of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiri
Phase 2
- Conditions
- Gastric or duodenal ulcers caused by low-dose aspirin
- Registration Number
- JPRN-jRCT2080221499
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Require long-term administration of low-dose aspirin (81 mg/day or 100 mg/day).
Confirmed to have a history of gastric or duodenal ulcer.
Exclusion Criteria
Confirmed to have acute gastroduodenal mucosal lesions, gastric or duodenal ulcer, or upper gastrointestinal (esophagus, stomach, duodenum) bleeding.
Confirmed to have reflux esophagitis or long segment Barrett's esophagus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method